Novel Naphthalene-Based Inhibitors of Trypanosoma brucei RNA Editing Ligase 1

Background Neglected tropical diseases, including diseases caused by trypanosomatid parasites such as Trypanosoma brucei, cost tens of millions of disability-adjusted life-years annually. As the current treatments for African trypanosomiasis and other similar infections are limited, new therapeutics are urgently needed. RNA Editing Ligase 1 (REL1), a protein unique to trypanosomes and other kinetoplastids, was identified recently as a potential drug target. Methodology/Principal Findings Motivated by the urgent need for novel trypanocidal therapeutics, we use an ensemble-based virtual-screening approach to discover new naphthalene-based TbREL1 inhibitors. The predicted binding modes of the active compounds are evaluated within the context of the flexible receptor model and combined with computational fragment mapping to determine the most likely binding mechanisms. Ultimately, four new low-micromolar inhibitors are presented. Three of the four compounds may bind to a newly revealed cleft that represents a putative druggable site not evident in any crystal structure. Conclusions/Significance Pending additional optimization, the compounds presented here may serve as precursors for future novel therapies useful in the fight against several trypanosomatid pathogens, including human African trypanosomiasis, a devastating disease that afflicts the vulnerable patient populations of sub-Saharan Africa.

[1]  William L. Jorgensen,et al.  FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006 .

[2]  C. Wang,et al.  Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. , 1995, Annual review of pharmacology and toxicology.

[3]  I. Coppens,et al.  The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action. , 1993, Acta tropica.

[4]  Achim Schnaufer,et al.  Complex management: RNA editing in trypanosomes. , 2005, Trends in biochemical sciences.

[5]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[6]  J. Andrew McCammon,et al.  Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei , 2008, Proceedings of the National Academy of Sciences.

[7]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[8]  A. Fairlamb,et al.  Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo. , 1980, Molecular and biochemical parasitology.

[9]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[10]  Rommie E. Amaro,et al.  An improved relaxed complex scheme for receptor flexibility in computer-aided drug design , 2008, J. Comput. Aided Mol. Des..

[11]  R. Kaminsky,et al.  The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. , 1997, Acta tropica.

[12]  Ian H. Gilbert,et al.  N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness , 2010, Nature.

[13]  D. Smith,et al.  Human African trypanosomiasis: an emerging public health crisis. , 1998, British medical bulletin.

[14]  C. Burri,et al.  Treatment of human African trypanosomiasis--present situation and needs for research and development. , 2002, The Lancet. Infectious diseases.

[15]  Dima Kozakov,et al.  Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..

[16]  M. Barrett,et al.  Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease , 2007, British journal of pharmacology.

[17]  Rommie E. Amaro,et al.  Ensemble-Based Virtual Screening Reveals Potential Novel Antiviral Compounds for Avian Influenza Neuraminidase , 2008, Journal of medicinal chemistry.

[18]  Markus Christen,et al.  The GROMOS software for biomolecular simulation: GROMOS05 , 2005, J. Comput. Chem..

[19]  Dima Kozakov,et al.  Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase , 2009, J. Comput. Aided Mol. Des..

[20]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[21]  Robert V. Swift,et al.  Functional and Structural Insights Revealed by Molecular Dynamics Simulations of an Essential RNA Editing Ligase in Trypanosoma brucei , 2007, PLoS neglected tropical diseases.

[22]  J. Keiser,et al.  Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment , 2001, Tropical medicine & international health : TM & IH.

[23]  K. Piller,et al.  The Two RNA Ligases of the Trypanosoma brucei RNA Editing Complex: Cloning the Essential Band IV Gene and Identifying the Band V Gene , 2001, Molecular and Cellular Biology.

[24]  Michael T. McManus,et al.  Identification of candidate mitochondrial RNA editing ligases from Trypanosoma brucei. , 2001, RNA.

[25]  H. Hashimi,et al.  Unexplained complexity of the mitochondrial genome and transcriptome in kinetoplastid flagellates , 2005, Current Genetics.

[26]  Robert V. Swift,et al.  Toward Understanding the Conformational Dynamics of RNA Ligation† , 2009, Biochemistry.

[27]  Sandor Vajda,et al.  Algorithms for computational solvent mapping of proteins , 2003, Proteins.

[28]  David Ozonoff,et al.  Novel Druggable Hot Spots in Avian Influenza Neuraminidase H5N1 Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor Ensemble , 2008, Chemical biology & drug design.

[29]  Ruben Abagyan,et al.  Comparative study of several algorithms for flexible ligand docking , 2003, J. Comput. Aided Mol. Des..

[30]  J. Pitera,et al.  Simulations of the estrogen receptor ligand-binding domain: affinity of natural ligands and xenoestrogens. , 2000, Journal of medicinal chemistry.

[31]  Robert V. Swift,et al.  Discovery and design of DNA and RNA ligase inhibitors in infectious microorganisms , 2009, Expert opinion on drug discovery.

[32]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[33]  Reza Salavati,et al.  An RNA Ligase Essential for RNA Editing and Survival of the Bloodstream Form of Trypanosoma brucei , 2001, Science.

[34]  Wilfred F van Gunsteren,et al.  Free energies of binding of polychlorinated biphenyls to the estrogen receptor from a single simulation , 2003, Proteins.

[35]  Zaida Luthey-Schulten,et al.  On the Evolution of Structure in Aminoacyl-tRNA Synthetases , 2003, Microbiology and Molecular Biology Reviews.

[36]  William L Jorgensen,et al.  FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Journal of the American Chemical Society.

[37]  L. Simpson,et al.  Uridine insertion/deletion RNA editing in trypanosome mitochondria: a complex business. , 2003, RNA.

[38]  X. Daura,et al.  Folding–unfolding thermodynamics of a β‐heptapeptide from equilibrium simulations , 1999, Proteins.

[39]  Stewart Shuman,et al.  The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases. , 2004, Current opinion in structural biology.

[40]  Sandor Vajda,et al.  Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. , 2007, Journal of medicinal chemistry.

[41]  A. Schnaufer,et al.  High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1. , 2004, Journal of molecular biology.

[42]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[43]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[44]  D. Durrheim,et al.  Current Concepts Control of Neglected Tropical Diseases , 2007 .